Corium International (CORI) stock price, revenue and financials

$463 M

CORI Mkt cap, 26-Nov-2018

$7.7 M

Corium International Revenue Q3, 2018

Corium International EBIT (Q3, 2018)-10 M

Corium International Cash, 30-Jun-201882.5 M

Corium International EV380.9 M

Annual

USD	FY, 2015	FY, 2016	FY, 2017
Revenue	40.9m	33.0m	31.9m
R&D expense	16.5m	21.7m	31.9m
General and administrative expense	11.2m	11.6m	13.2m
Operating expense total	61.9m	61.9m	71.6m
Depreciation and amortization	622.0k	659.0k	690.0k
EBIT	(21.0m)	(28.9m)	(39.8m)
EBIT margin, %	(51%)	(88%)	(125%)
Interest expense	7.4m	7.9m	8.3m
Interest income	23.0k	171.0k	278.0k
Pre tax profit	(28.4m)	(36.7m)	(47.8m)
Income tax expense	3.0k	3.0k	7.0k

Quarterly

USD	Q2, 2014	Q3, 2014	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Revenue	10.7m	10.2m	10.6m	7.5m	7.0m	10.6m	7.0m	7.3m	8.1m	9.3m	10.1m	7.7m
R&D expense	1.3m	1.6m	3.5m	4.5m	5.6m	5.5m	6.0m	7.5m	9.1m	10.2m	12.0m	8.3m
General and administrative expense	1.2m	3.5m	2.8m	3.0m	3.0m	3.1m	3.0m	3.0m	3.3m	3.3mwdxefcqufszuzezftuxetqsqxt	4.1m	3.3m
Operating expense total	11.5m	13.6m	14.6m	15.0m	15.5m	16.2m	15.4m	16.4m	19.5m	20.6m	23.6m	17.7m
Depreciation and amortization	131.0k	138.0k	141.0k	159.0k	162.0k	168.0k	177.0k	178.0k	159.0k	177.0k	181.0k	183.0k
EBIT	(794.0k)	(3.4m)	(4.0m)	(7.4m)	(8.6m)	(5.6m)	(8.4m)	(9.0m)	(11.4m)	(11.3m)	(13.5m)	(10.0m)
EBIT margin, %	(7%)	(33%)	(38%)	(99%)	(123%)	(52%)	(121%)	(123%)	(140%)	(121%)	(134%)	(130%)
Interest expense	1.8m	1.6m	1.9m	2.0m	2.0m	2.0m	2.0m	2.0m	2.1m	2.1m	2.4m	3.4m
Interest income	1.0k	2.0k	5.0k	30.0k	58.0k	54.0k	28.0k	44.0k	77.0k	122.0k	163.0k	332.0k
Pre tax profit	3.5m	(5.0m)	(5.9m)	(9.4m)	(10.5m)	(7.5m)	(10.4m)	(11.0m)	(13.4m)	(13.3m)	(18.0m)	(12.4m)
Income tax expense			2.0k	3.0k	3.0k	3.0k	2.0k	2.0k	2.0k	2.0k	2.0k	2.0k

Annual

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Cash	36.4m	72.2m	39.8m	57.5m
Accounts Receivable	4.2m	4.5m	4.3m	4.6m
Inventories	1.3m	1.4m	2.4m	2.3m
Current Assets	45.8m	81.8m	48.3m	65.6m
PP&E	12.7m	11.6m	11.1m	12.2m
Total Assets	65.7m	100.7m	67.2m	84.9m
Accounts Payable	2.5m	4.0m	2.7m	4.0m
Current Liabilities	8.5m	9.8m	8.0m	24.3m
Long-term debt	38.2m	49.8m	51.0m	39.0m
Total Debt			51.0m	39.0m
Total Liabilities			64.3m	68.6m
Additional Paid-in Capital	114.1m	166.1m	170.3m	231.5m
Retained Earnings	(102.3m)	(130.8m)	(167.5m)	(215.3m)
Total Equity	11.8m	35.3m	2.9m	16.2m
Debt to Equity Ratio			17.9 x	2.4 x
Debt to Assets Ratio			0.8 x	0.5 x
Financial Leverage	5.6 x	2.9 x	23.5 x	5.2 x

Quarterly

USD	Q2, 2014	Q3, 2014	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Cash	5.3m	44.2m	29.5m	63.0m	54.4m	47.4m	33.1m	40.6m	66.6m	45.2m	94.2m	82.5m
Accounts Receivable	4.3m	4.5m	4.6m	3.1m	3.5m	4.1m	2.2m	3.4m	4.6m	4.9m	4.2m	3.6m
Inventories	3.0m	3.1m	3.3m	2.9m	3.2m	2.8m	1.9m	2.7m	2.5m	2.5m	2.0m	1.7m
Current Assets	17.4m	55.0m	40.2m	71.0m	62.9m	56.3m	39.2m	47.7m	75.1m	54.3m	101.1m	88.9m
PP&E	12.1m	12.5m	11.8m	11.6m	11.3m	11.1m	11.7m	12.0m	12.5m	12.9m	14.2m	15.8m
Total Assets	36.9m	74.9m	59.3m	90.2m	82.5m	75.8m	58.6m	67.5m	95.5m	74.4m	122.5m	112.1m
Accounts Payable	1.8m	2.6m	3.6m	2.7m	3.4m	3.1m	3.8m	3.7m	5.4m	7.7m	6.3m	4.5m
Current Liabilities	13.4m	11.8m	9.0m	7.5m	8.9m	8.1m	8.5m	8.7m	10.7m	38.8m	12.5m	11.7m
Long-term debt	38.9m	38.9m	49.7m	50.2m	50.7m	51.1m	50.9m	51.5m	52.0m	26.0m	350.0k	337.0k
Total Debt	38.9m	38.9m	49.7m	50.2m	50.7m	51.1m	50.9m	51.5m	52.0m	26.0m	350.0k	337.0k
Total Liabilities	97.3m	57.4m	64.7m	63.2m	65.0m	64.6m	64.9m	65.4m	68.0m	69.9m	86.2m	87.2m
Common Stock	2.0k	18.0k
Additional Paid-in Capital	(29.9m)	113.4m	116.7m	167.1m	168.2m	169.3m	171.6m	191.1m	229.8m	232.9m	282.9m	283.8m
Retained Earnings	(91.0m)	(96.0m)	(122.1m)	(140.2m)	(150.7m)	(158.2m)	(177.9m)	(189.0m)	(202.3m)	(228.6m)	(246.6m)	(259.0m)
Total Equity	(120.9m)	17.5m	(5.4m)	27.0m	17.5m	11.1m	(6.3m)	2.1m	27.5m	4.4m	36.3m	24.9m
Debt to Equity Ratio											0 x	0 x
Debt to Assets Ratio											0 x	0 x
Financial Leverage	-0.3 x	4.3 x	-11 x	3.3 x	4.7 x	6.8 x	-9.4 x	31.5 x	3.5 x	16.9 x	3.4 x	4.5 x

Annual

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Accounts Receivable	(1.0m)	(293.0k)	125.0k	(305.0k)
Inventories	(255.0k)	(75.0k)	478.0k	124.0k
Accounts Payable	700.0k	1.4m	(1.2m)	1.4m
Cash From Operating Activities	(11.4m)	(20.7m)	(29.1m)	(37.2m)
Purchases of PP&E	(3.2m)	(973.0k)	(1.4m)	(2.3m)
Cash From Investing Activities	(3.7m)	(1.7m)	(3.0m)	(2.5m)
Long-term Borrowings	(484.0k)	(67.0k)	(72.0k)	(77.0k)
Cash From Financing Activities	37.9m	58.3m	(298.0k)	57.3m
Interest Paid	4.7m	5.6m	5.9m	6.5m
Income Taxes Paid	2.0k	2.0k	3.0k	4.0k

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017
Depreciation and Amortization					141.0k	159.0k	162.0k	168.0k	177.0k	178.0k
Accounts Receivable	4.3m	4.5m	4.1m	4.9m	4.6m	3.1m	3.5m	4.1m	2.2m	3.4m	4.6m
Inventories									1.9m	2.7m
Accounts Payable	1.8m	2.6m	3.4m	2.6m	3.6m	2.7m	3.4m	3.1m	3.8m	3.7m	5.4m

Report incorrect company information

View Corium International profile

Competitors

Kiniksa Pharmaceuticals

Healthcare - Public

Sartorius Stedim BioOutsource

Healthcare - Subsidiary

Healthcare - Public

Healthcare - Public

Compare competitors